Optic disc

Global Ophthalmoscopes Market Report to 2030: Rising Incidence of Eye Diseases Drives Growth - ResearchAndMarkets.com

Retrieved on: 
måndag, maj 22, 2023

Portable ophthalmoscopes are handheld devices used to examine the eye's interior including the retina, optic disc, and blood vessels.

Key Points: 
  • Portable ophthalmoscopes are handheld devices used to examine the eye's interior including the retina, optic disc, and blood vessels.
  • Advancements in artificial intelligence (AI) and machine learning are being incorporated into ophthalmoscopes, allowing for the automatic detection and diagnosis of eye diseases.
  • AI-powered ophthalmoscopes can analyze images of the retina and optic nerve, identifying patterns and anomalies that may be indicative of eye diseases.
  • Such a rise in the incidence of eye disorders across the globe is anticipated to propel market growth.

Global Ophthalmoscopes Market Report (2022 to 2027) - Key Players Include Heine USA, Dino Lite Europe, Iridex and Halma - ResearchAndMarkets.com

Retrieved on: 
onsdag, juli 6, 2022

The "Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ophthalmoscopes Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The rising prevalence of eye diseases is driving the growth of the eye testing equipment market.
  • Around 596 million people are suffering from distance vision impairment globally, of which 43 million people are blind.
  • Manufacturers' enhanced efforts to promote awareness about developments in ophthalmoscope technology are driving the global ophthalmoscopes market expansion.

Global Proliferative Diabetic Retinopathy Market (2022 to 2027) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
torsdag, april 14, 2022

Proliferative diabetic retinopathy is the most advanced stage of diabetic retinopathy which is characterized by the growth of new vessels on the surface of the retina.

Key Points: 
  • Proliferative diabetic retinopathy is the most advanced stage of diabetic retinopathy which is characterized by the growth of new vessels on the surface of the retina.
  • Hence, the rising prevalence of diabetes is directly contributing to the further increase in the prevalence of proliferative diabetic retinopathy (PDR).
  • North America is expected to hold a major market share in the global proliferative diabetic retinopathy market due to rising prevalence of diabetes and diabetic retinopathy and availability of advanced technology and minimally invasive laser technique in this region.
  • According to the Centers for Disease Control and Prevention, approximately 4.2 million adults had diabetic retinopathy and 655,000 had vision-threatening diabetic retinopathy.

Canadian Ophthalmological Society aims to reduce blind spots about vision loss during Glaucoma Awareness Month

Retrieved on: 
måndag, januari 11, 2021

During Glaucoma Awareness Month, they stress the importance of regular eye exams for detecting glaucoma, given that as much as 40 per cent of vision can be lost without a person noticing it.

Key Points: 
  • During Glaucoma Awareness Month, they stress the importance of regular eye exams for detecting glaucoma, given that as much as 40 per cent of vision can be lost without a person noticing it.
  • "While there currently is no cure, the good news is that vision loss from glaucoma can be prevented through early diagnosis with yearly, comprehensive eye exams."
  • These nerve fibres become damaged by pressure that builds up inside the eye, known as intraocular pressure (IOP), which can cause blind spots and vision loss.
  • The Canadian Ophthalmological Society (COS) is the national, recognized authority on eye and vision care inCanada.

Canon Xephilio OCT-A1 Optical Coherence Tomography Device Receives FDA 510(k) Clearance

Retrieved on: 
tisdag, september 17, 2019

MELVILLE, N.Y., Sept.17, 2019 /PRNewswire/ -- Expanding the company's lineup of eye-care product offerings, Canon U.S.A., Inc., a leader in digital imaging solutions, is pleased to announce the new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence Tomography device from Canon Inc.

Key Points: 
  • MELVILLE, N.Y., Sept.17, 2019 /PRNewswire/ -- Expanding the company's lineup of eye-care product offerings, Canon U.S.A., Inc., a leader in digital imaging solutions, is pleased to announce the new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence Tomography device from Canon Inc.
  • The Xephilio OCT-A1 Optical Coherence Tomography device has received FDA 510(k) clearance for sale in the United States of America1.
  • The Xephilio OCT-A1 Optical Coherence Tomography device, together with the required RX Capture software, computer and LCD monitor (collectively, the "Xephilio OCT-A1 System"), is an optical coherence tomography system indicated for the in-vivo imaging and measurement of the retina, retinal nerve fiber layer, and optic disc.
  • 3 Ben Szirth, Ph.D., is a paid consultant who providesadvisory and consulting services to Canon U.S.A. on a regular basis.